Press Releases April 20, 2026 04:30 PM

Fluence Energy, Inc. Announces Second Quarter Earnings Release Date, Conference Call and Webcast

Fluence Energy announces date and details for Q2 2026 earnings release and conference call

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
FLNC

Fluence Energy, Inc., a leader in intelligent energy storage and optimization software for renewables, announced it will release its first quarter 2026 earnings after market close on May 6, 2026, with a follow-up conference call on May 7. The company provided details on how analysts and the public can participate in the call or access recordings and supplementary materials via its website. Fluence highlights its ongoing commitment to helping build a more resilient grid and advancing renewable energy solutions worldwide.

Fluence Energy, Inc. Announces Second Quarter Earnings Release Date, Conference Call and Webcast
FLNC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Fluence Energy will report Q1 2026 earnings on May 6, 2026, with a conference call scheduled on May 7 to discuss results.
  • The company operates globally in energy storage and software solutions supporting renewable energy integration and grid resilience.
  • Fluence has contracted, deployed, and manages gigawatts of projects across nearly 50 markets, emphasizing its role in the renewable energy sector.

ARLINGTON, Va., April 20, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), announced today that it will report earnings for the first quarter ended March 31st, 2026 on Wednesday, May 6th, 2026, after market close.

The Company will conduct a teleconference starting at 8:30 a.m. EST on Thursday, May 7th, 2026, to discuss the results. To participate, analysts are required to register by clicking Fluence Energy Q2 2026 Earnings Call Registration Link. Once registered, analysts will be issued a unique PIN number and dial-in number. Analysts are encouraged to register at least 15 minutes before the scheduled start time.

General audience participants, and non-analysts are encouraged to join the teleconference in a listen-only mode at: Listen-Only Mode - Webcast Link, or on http://Fluenceenergy.com by selecting Investors, News & Events, and Events & Presentations. Supplemental materials that may be referenced during the teleconference will be available at: www.fluenceenergy.com, by selecting Investors, News & Events, and Events & Presentations.

A replay of the conference call will be available after 1 p.m. on Thursday, May 7th, 2026. The replay will be available on the company’s website at http://Fluenceenergy.com by selecting Investors, News & Events, and Events & Presentations.

About Fluence

Fluence Energy, Inc. (Nasdaq: FLNC) is a global market leader delivering intelligent energy storage and optimization software for renewables and storage. The Company's solutions and operational services are helping to create a more resilient grid and unlock the full potential of renewable portfolios. With gigawatts of projects successfully contracted, deployed, and under management across nearly 50 markets, the Company is transforming the way we power our world for a more sustainable future.

For more information, visit our website, or follow us on Linkedln. To stay up to date on the latest industry insights, sign up for Fluence's Full Potential Blog.

Analyst Contact
Chris Shelton, Vice President of Investor Relations & Sustainability
Email: [email protected]

Media Contact
Shayla Ebsen, Director of Communications
Email: [email protected]
Phone: +1 (605) 645-7486


Risks

  • Financial performance for the quarter may not meet market expectations, impacting stock price and investor confidence in the renewable energy sector.
  • Market volatility and global economic uncertainties could affect deployment and contracting of new projects in energy storage.
  • Technological, regulatory, or market challenges in the renewable energy and grid infrastructure segments may impede growth forecasts and project execution.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026